Clinical Trials

Showing trials with last updates posted in 2026.

NCT03251989 | COMPLETED
326 participants

Rare CNS Tumors Outcomes &Risk

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-01
Start Date:
2017-08-21
Completion:
2025-05-06
Conditions
  • High Grade Meningioma
  • Ependymoma
  • Medulloblastoma
  • PNET
  • Primary CNS Sarcoma
No Results Yet
NCT03217032 | NOT_YET_RECRUITING | PHASE1
10 participants

Lentiviral FVIII Gene Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2027-06-01
Completion:
2028-05-31
Conditions
  • Hemophilia A
Interventions
  • BIOLOGICAL
No Results Yet
NCT03206099 | RECRUITING
20000 participants

NIAID Centralized Sequencing Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-01
Start Date:
2017-07-31
Completion:
2029-12-31
Conditions
  • Atopy
  • Primary Immunodeficiency
  • Autoimmunity
  • Autoinflammation
No Results Yet
NCT03021460 | COMPLETED | PHASE1
20 participants

Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2017-01-31
Completion:
2025-12-31
Conditions
  • Metastatic Melanoma
  • Stage III Cutaneous Melanoma AJCC v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Unresectable Melanoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page